SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-015643
Filing Date
2023-05-05
Accepted
2023-05-05 17:03:33
Documents
15
Period of Report
2023-05-05
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42135
2 ex3-1.htm EX-3.1 15431
3 ex3-1_001.jpg GRAPHIC 1469189
4 ex3-1_002.jpg GRAPHIC 33637
  Complete submission text file 0001493152-23-015643.txt   2303119

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ppcb-20230505.xsd EX-101.SCH 3224
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ppcb-20230505_lab.xml EX-101.LAB 34240
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ppcb-20230505_pre.xml EX-101.PRE 22357
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3485
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 61-03-9882-0780
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

IRS No.: 300662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54878 | Film No.: 23894854
SIC: 2834 Pharmaceutical Preparations